Business Context and Reporting Period
This Form 6-K filing by InflaRx N.V. is dated September 12, 2025, covering events occurring in September 2025. The report addresses the Company's status regarding Nasdaq Stock Market listing compliance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance regarding share price.
Material Changes
The primary material change reported is the resolution of a listing deficiency. On July 11, 2025, the Company received notice of non-compliance with Nasdaq Listing Rule 5450(a)(1) due to a closing bid price below $1.00 for 30 consecutive business days. As of September 11, 2025, Nasdaq confirmed that the closing bid price remained at or above $1.00 per share for 10 consecutive business days (August 27 to September 10, 2025), resulting in the closure of the compliance matter.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. The primary risk addressed was the potential delisting due to low share price, which has been mitigated by regaining compliance. No other contingencies or unusual items are disclosed in this text.
Investor Verification Points
- Verify the current trading price of InflaRx N.V. ordinary shares to ensure continued compliance with the $1.00 minimum bid price requirement.
- Review the attached Press Release (Exhibit 99.1) for any additional context not included in the Form 6-K text.
- Monitor future filings for any recurrence of non-compliance notices from Nasdaq.